Acer Therapeutics Inc (ACER)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -11,846 | -9,179 | -15,374 | -10,953 | -7,680 |
| Depreciation Amortization | 39 | 21 | 71 | 51 | 33 |
| Accounts receivable | 5,000 | 5,000 | -5,000 | N/A | 0 |
| Accounts payable and accrued liabilities | 2,086 | 614 | -266 | -583 | 136 |
| Other Working Capital | 401 | 3,541 | 13,450 | 11,002 | 16,303 |
| Other Operating Activity | -8,546 | -3,009 | 6,985 | 1,769 | 452 |
| Operating Cash Flow | $-12,866 | $-3,013 | $-135 | $1,285 | $9,243 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -31 | -29 | -55 | -35 | -15 |
| Investing Cash Flow | $-31 | $-29 | $-55 | $-35 | $-15 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 11,530 | 11,530 | 4,000 | 4,000 | 4,000 |
| Debt Repayment | -725 | -725 | N/A | N/A | N/A |
| Common Stock Issued | 3,851 | 327 | 3,139 | 3,139 | 3,139 |
| Financing Cash Flow | $14,656 | $11,132 | $7,139 | $7,139 | $7,139 |
| Beginning Cash Position | 12,711 | 12,711 | 5,762 | 5,762 | 5,762 |
| End Cash Position | 14,470 | 20,800 | 12,711 | 14,152 | 22,128 |
| Net Cash Flow | $1,759 | $8,090 | $6,949 | $8,390 | $16,367 |
| Free Cash Flow | |||||
| Operating Cash Flow | -12,866 | -3,013 | -135 | 1,285 | 9,243 |
| Capital Expenditure | -31 | -29 | -55 | -35 | -15 |
| Free Cash Flow | -12,897 | -3,042 | -190 | 1,251 | 9,228 |